For Doctors in a Hurry
- Clinicians lack data on whether virtual visits for new neurology patients provide care equivalent to traditional in-person evaluations.
- The researchers conducted a retrospective cohort study of 16,404 propensity score-matched adult patients across three academic medical centers.
- Neurologic emergency department visits and hospitalizations within 90 days were similar between virtual and in-person groups (p = 0.23).
- The authors concluded that virtual and in-person new patient neurology visits result in comparable downstream health care utilization.
- Virtual neurology visits appear to be a safe, viable option for initial patient evaluation in clinical practice.
The Evolution of Virtual Neurologic Assessment
The rapid integration of telemedicine has transformed outpatient specialty care, shifting from an emergency pandemic response to a permanent fixture in clinical practice [1]. While mobile health applications and remote monitoring tools have expanded the reach of evidence-based medicine, clinicians often face uncertainty regarding which patients are best suited for virtual rather than physical examinations [2, 3]. Previous research suggests that digital interventions can be cost-effective and improve access for patients with chronic conditions, yet the diagnostic reliability of a virtual first encounter remains a point of professional debate [4, 5]. As health systems move toward blended care models, establishing whether remote consultations provide equivalent safety and follow-up outcomes is essential for maintaining standards of care [1]. A new multicenter analysis now provides data on how virtual initial evaluations influence subsequent healthcare utilization across diverse neurologic presentations.
Methodology and Propensity Score Matching
To evaluate the clinical trajectory of adults following an initial outpatient neurology consultation, researchers conducted a retrospective multicenter cohort study involving three academic medical centers. The study period spanned from September 2020 through December 2021, a timeframe capturing a transition in healthcare delivery where both virtual and in-person options were widely available. Data were extracted from the Vizient Clinical Data Base and the Clinical Practice Solutions Center databases, which are comprehensive repositories that track patient outcomes and resource use across large health systems. The initial dataset was substantial, identifying 10,428 virtual and 36,767 in-person neurology new outpatient visits. This large sample size provided the statistical power necessary to detect even subtle differences in how patients utilized healthcare services following their first appointment.
Primary Outcomes in Healthcare Utilization
To ensure a rigorous comparison, the researchers utilized propensity score matching (a statistical technique that pairs patients with similar baseline characteristics to mimic the balance of a randomized trial). This process accounted for demographics, clinical characteristics, and previous healthcare utilization, resulting in a balanced cohort of 8,202 virtual visits matched to 8,202 in-person visits. The primary analysis demonstrated that the modality of the initial consultation did not significantly alter the trajectory of subsequent neurologic care. Neurology follow-up within 90 days did not differ between virtual and in-person visits, with rates of 24.6% and 23.7%, respectively (p = 0.18). While the researchers noted that thirty-day neurology clinic follow-up was slightly lower after virtual visits, this initial variance did not persist over longer clinical horizons. In fact, neurology clinic follow-up at 6 months and 1 year was similar between the virtual and in-person groups, suggesting that telemedicine does not disrupt long-term continuity of care for new neurology patients.
Safety Signals and All-Cause Utilization
Safety and diagnostic stability were further supported by the rates of acute healthcare utilization following the index visit. The study found that neurologic emergency department visits within 90 days were similar between groups, occurring in 0.9% of the virtual cohort and 0.8% of the in-person cohort (p = 0.23). Similarly, the frequency of neurologic hospitalizations within 90 days was comparable between groups, with rates of 1.8% for virtual patients and 1.7% for those seen in person (p = 0.47). These findings indicate that the use of virtual platforms for initial neurologic assessments does not lead to an increase in urgent complications or missed diagnoses requiring acute intervention within the first three months of care. Furthermore, all-cause emergency department visits within 90 days were comparable (1.8% virtual vs 1.7% in-person, p = 0.59), as were all-cause hospitalizations (2.2% virtual vs 1.8% in-person, p = 0.13), suggesting that the virtual format did not lead to an increase in urgent medical presentations across the broader spectrum of patient health.
Divergent Outcomes by Clinical Presentation
Granular analysis of chief complaints reveals distinct patterns that may guide clinical triage. For patients presenting with dementia, the researchers found that 90-day follow-up was higher after in-person visits, potentially reflecting the complexity of cognitive examinations and the need for face-to-face caregiver coordination. In contrast, for patients with Parkinson disease and multiple sclerosis, 30-day and 90-day follow-up was higher after virtual visits, suggesting that the reduced travel burden associated with telemedicine may facilitate more consistent clinical monitoring for these populations. For patients presenting with headache, 90-day follow-up was also higher after virtual visits. However, the researchers observed that testing was more frequent after in-person visits for certain chief complaints, suggesting that physical presence may lower the threshold for initiating ancillary diagnostic workups. These findings imply that while virtual visits are effective for many, the choice of modality should be tailored to the specific diagnostic requirements and follow-up needs of the individual neurologic condition.
References
1. Zangani C, Ostinelli EG, Smith K, et al. Impact of the COVID-19 Pandemic on the Global Delivery of Mental Health Services and Telemental Health: Systematic Review. JMIR Mental Health. 2022. doi:10.2196/38600
2. Mosa ASM, Yoo I, Sheets L. A Systematic Review of Healthcare Applications for Smartphones. BMC Medical Informatics and Decision Making. 2012. doi:10.1186/1472-6947-12-67
3. Fonseca MHD, Kovaleski F, Picinin CT, Pedroso B, Rubbo P. E-Health Practices and Technologies: A Systematic Review from 2014 to 2019. Healthcare. 2021. doi:10.3390/healthcare9091192
4. Senyel D, Senn KC, Boyd JH, Nagels K. A systematic review of telemedicine for neuromuscular diseases: components and determinants of practice. BMC Digital Health. 2024. doi:10.1186/s44247-024-00078-9
5. Gentili A, Failla G, Melnyk A, et al. The cost-effectiveness of digital health interventions: A systematic review of the literature. Frontiers in Public Health. 2022. doi:10.3389/fpubh.2022.787135
